The dental considerations of outpatient inhalation therapy
Abstract
Keywords
Full Text:
PDFReferences
Henning A, Hein S, Schneider M, Bur M, Lehr CM. Pulmonary drug delivery: medicines for inhalation. Handb Exp Pharmacol 2010;197:171-2. doi: 10.1007/978-3-642-00477-3_6.
Mallet JP, Diot P, Lemarié E. Inhalation route for administration of systemic drugs. Rev Mal Respir 1997;14(4):257-67.
Atkins PJ, Crowder TM. The design and development of inhalational drug delivery systems. In: Hickey AJ, editor. Pharmaceutical inhalation aerosol technology. Boca Raton (Fl): CRC Press; 2003. p. 279-310.
Bilbao A, Spanagel R. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Med 2022;20(1):259. doi: 10.1186/s12916-022-02459-1.
Schauer GL, King BA, Bunnell RE, Promoff G, McAfee TA. Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014. Am J Prev Med 2016;50(1):1-8. doi: 10.1016/j.amepre.2015.05.027.
Freeman TP, Hindocha C, Green SF, Bloomfield MAP. Medicinal use of cannabis based products and cannabinoids. BMJ 2019;365:l1141. doi: 10.1136/bmj.l1141.
Gieringer DH. Cannabis “vaporization”: A promising strategy for smoke harm reduction. J Cannabis Ther 2001;1(3-4):153-70.
Godara N, Godara R, Khullar M. Impact of inhalation therapy on oral health. Lung India 2011;28(4):272-5. doi: 10.4103/0970-2113.85689.
Ibrahim M, Verma R, Garcia-Contreras L. Inhalation drug delivery devices: technology update. Med Devices (Auckl) 2015;8:131-9. doi: 10.2147/MDER.S48888.
Singh D, Lippmann S. Vaping medical marijuana. Postgrad Med 2018;130(2):183-5. doi: 10.1080/00325481.2018.1413281.
Dhand R, Dolovich M, Chipps B, Myers TR, Restrepo R, Farrar JR. The role of nebulized therapy in the management of COPD: evidence and recommendations. COPD 2012;9(1):58-72. doi: 10.3109/15412555.2011.630047.
Rau JL. The inhalation of drugs: advantages and problems. Respir Care 2005;50(3):367-82.
Levy ML, Carroll W, Izquierdo Alonso JL, Keller C, Lavorini F, Lehtimäki L. Understanding dry powder inhalers: key technical and patient preference attributes. Adv Ther 2019;36(10):2547-57. doi: 10.1007/s12325-019-01066-6.
Bai TR. Beta 2 adrenergic receptors in asthma: a current perspective. Lung 1992;170(3):125-41. doi: 10.1007/BF00174316.
Garzon-Siatoya WT, Carrillo-Martin I, Chiarella SE, Gonzalez- -Estrada A. State-of-the-art beta-adrenoreceptor agonists for the treatment of asthma. Expert Opin Pharmacother 2022;23(2):243-54. doi: 10.1080/14656566.2021.1988074.
Wołkow P. Leki układu oddechowego. In: Korbut R, editor. Farmakologia. II ed. Warszawa: PZWL; 2019. p. 397-412.
Moulton BC, Fryer AD. Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD. Br J Pharmacol 2011;163(1):44-52. doi: 10.1111/j.1476-5381.2010.01190.x.
Calzetta L, Rogliani P, Matera MG, Cazzola M. A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD. Chest 2016;149(5):1181-96. doi: 10.1016/j.chest.2016.02.646.
Brittain D, D’Andrea P, Gruen E, Hosoe M, Jain D, Jauernig J, et al. A review of the unique drug development strategy of indacaterol acetate/glycopyrronium bromide/mometasone furoate: a first-in-class, once-daily, single-inhaler, fixed-dose combination treatment for asthma. Adv Ther 2022;39(6):2365-78. doi: 10.1007/s12325-021-02025-w.
Suissa S, Dell’Aniello S, Ernst P. Comparative effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: cohort study in real-world clinical practice. Chest 2020;157(4):846-55. doi: 10.1016/j.chest.2019.11.007.
Bellocchio L, Inchingolo AD, Inchingolo AM, Lorusso F, Malcangi G, Santacroce L, et al. Cannabinoids drugs and oral health-from recreational side-effects to medicinal purposes: a systematic review. Int J Mol Sci 2021;22(15):8329. doi: 10.3390/ijms22158329.
Chibly AM, Aure MH, Patel VN, Hoffman MP. Salivary gland function, development, and regeneration. Physiol Rev 2022;102(3):1495-552. doi: 10.1152/physrev.00015.2021.
Proctor GB. Muscarinic receptors and salivary secretion. J Appl Physiol (1985) 2006;100(4):1103-4. doi: 10.1152/japplphysiol.01546.2005.
Tuğrul E. The relationship between inhaler use and oral problems in patients with COPD and affecting factors: a cross-sectional study. Florence Nightingale J Nurs 2022;30(2):196-201. doi: 10.54614/FNJN.2022.21327.
Ryberg M, Möller C, Ericson T. Effect of beta 2-adrenoceptor agonists on saliva proteins and dental caries in asthmatic children. J Dent Res 1987;66(8):1404-6. doi: 10.1177/00220345870660082401.
Alcázar Navarrete B, Gómez-Moreno G, Aguilar-Salvatierra A, Guardia J, Romero Palacios PJ. Xerostomia relates to the degree of asthma control. J Oral Pathol Med 2015;44(4):273-7. doi: 10.1111/jop.12228.
Robo I, Çuni O, Gina E, Heta S, Mavriqi L. Marijuana usage, the effects in oral health. Intern J Dent Med 2018;4(1):1-4. doi: 10.11648/j.ijdm.20180401.11.
Prestifilippo JP, Fernández-Solari J, de la Cal C, Iribarne M, Suburo AM, Rettori V, et al. Inhibition of salivary secretion by activation of cannabinoid receptors. Exp Biol Med (Maywood) 2006;231(8):1421-9. doi: 10.1177/153537020623100816.
Veiga N, Aires D, Douglas F, Pareira M, Vaz A, Rama L, et al. Dental caries: A review. J Dent Oral Health 2016;2(5):043.
Ryberg M, Möller C, Ericson T. Saliva composition and caries development in asthmatic patients treated with beta 2-adrenoceptor agonists: a 4-year follow-up study. Scand J Dent Res 1991;99(3):212-8. doi: 10.1111/j.1600-0722.1991.tb01887.x.
Heidari A, Seraj B, Shahrabi M, Maghsoodi H, Kharazifard MJ, Zarabian T. Relationship Between Different Types and Forms of Anti-Asthmatic Medications and Dental Caries in Three to 12 Year Olds. J Dent (Tehran) 2016;13(4):238-43.
Sköld UM, Birkhed D, Xu JZ, Lien KH, Stensson M, Liu JF. Risk factors for and prevention of caries and dental erosion in children and adolescents with asthma. J Dent Sci 2022;17(3):1387-400. doi: 10.1016/j.jds.2022.03.007.
Mattes RD, Shaw LM, Engelman K. Effects of cannabinoids (marijuana) on taste intensity and hedonic ratings and salivary flow of adults. Chem Senses 1994;19(2):125-140. doi: 10.1093/chemse/19.2.125.
Kargul B, Tanboga I, Ergeneli S, Karakoc F, Dagli E. Inhaler medicament effects on saliva and plaque pH in asthmatic children. J Clin Pediatr Dent 1998;22(2):137-40.
O’Sullivan EA, Curzon MEJ. Drug treatments for asthma may cause erosive tooth damage. BMJ 1998;317(7161):820.
Crowell MD, Zayat EN, Lacy BE, Schettler-Duncan A, Liu MC. The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study. Chest 2001;120(4):1184-9. doi: 10.1378/chest.120.4.1184.
Dekhuijzen PNR, Batsiou M, Bjermer L, Bosnic-Anticevich S, Chrystyn H, Papi A, et al. Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device. Respir Med 2016;120:54-63. doi: 10.1016/j.rmed.2016.09.015.
Gümrü B, Akkitap MP. Oral candidiasis as a local adverse effect of inhaled corticosteroids: what the dental practitioner should know. BSJ Health Sci 2022;5(1):107-15.
Sharma S, Gaur P, Gupta S, Kant S. Impact of asthma on oral health: A review. Int J Recent Sci Res 2018;9(5):26512-4.
Arias-Guillen CJ, Prado DA, Tuon R, Scudine K, Gavião M, Lamy E, et al. Impact of asthma on children´s gustatory sensitivity, masticatory and feeding behaviors. Physiol Behav 2020;223:112961. doi: 10.1016/j.physbeh.2020.112961.
Ciancio SG. Medications’ impact on oral health. J Am Dent Assoc 2004;135(10):1440-69. doi: 10.14219/jada.archive.2004.0055.
Bergdahl M, Bergdahl J. Perceived taste disturbance in adults: prevalence and association with oral and psychological factors and medication. Clin Oral Investig 2002;6(3):145-9. doi: 10.1007/s00784-002-0169-0.
Yoshida R, Niki M, Jyotaki M, Sanematsu K, Shigemura N, Ninomiya Y. Modulation of sweet responses of taste receptor cells. Semin Cell Dev Biol 2013;24(3):226-31. doi: 10.1016/j.semcdb.2012.08.004.
Zalewska A, Zatoński M, Jabłonka-Strom A, Paradowska A, Kawala B, Litwin A. Halitosis – a common medical and social problem. A review on pathology, diagnosis and treatment. Acta Gastroenterol Belg 2012;75(3):300-9.
Ginting ME, Wihardja R, Carolina DN. Periodontal clinical features of bronchial asthma patient using inhalation drugs. Padjadjaran J Dent 2018;33(3):217-25.
Slots J. Periodontitis: facts, fallacies and the future. Periodontol 2000 2017;75(1):7-23. doi: 10.1111/prd.12221.
Beeraka SS, Natarajan K, Patil R, Manne RK, Prathi VS, Kolaparthi VS. Clinical and radiological assessment of effects of long-term corticosteroid therapy on oral health. Dent Res J (Isfahan) 2013;10(5):666-73.
Thomas MS, Parolia A, Kundabala M, Vikram M. Asthma and oral health: a review. Aust Dent J 2010;55(2):128-33. doi: 10.1111/j.1834-7819.2010.01226.x.
Gu Z, Singh S, Niyogi RG, Lamont GJ, Wang H, Lamont RJ, et al. Marijuana-derived cannabinoids trigger a CB2/PI3K axis of suppression of the innate response to oral pathogens. Front Immunol 2019;10:2288. doi: 10.3389/fimmu.2019.02288.
Scott DA, Dukka H, Saxena D. Potential Mechanisms Underlying Marijuana-Associated Periodontal Tissue Destruction. J Dent Res 2022;101(2):133-42. doi: 10.1177/00220345211036072.
Yao SG, Fine JB. Consumption of cannabis and effects on periodontal oral health. J Calif Dent Assoc 2017;45(9):475-81.
Ayinampudi BK, Gannepalli A, Pacha VB, Kumar JV, Khaled S, Naveed MA. Association between oral manifestations and inhaler use in asthmatic and chronic obstructive pulmonary disease patients. J Dr NTR Univ Health Sci 2016;5(1):17-23.
Mirza N, Kasper Schwartz S, Antin-Ozerkis D. Laryngeal findings in users of combination corticosteroid and bronchodilator therapy. Laryngoscope 2004;114(9):1566-9.
Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004;126(1):213-9.
Lozano AC, Pérez MGS, Esteve CG. Dental considerations in patients with respiratory problems. J Clin Exp Dent 2011;3(3):e222-7.
Christensen GJ. Why clean your tongue? J Am Dent Assoc 1998;129(11):1605-7. doi: 10.14219/jada.archive.1998.0109.
Rošin-Grget K, Peroš K, Sutej I, Bašić K. The cariostatic mechanisms of fluoride. Acta Med Acad 2013;42(2):179-88. doi: 10.5644/ama2006-124.85.
Triana BEG, Ali AH, León IBG. Mouth breathing and its relationship to some oral and medical conditions: physiopathological mechanisms involved. Revista Habanera de Ciencias Médicas 2016;15(2):200-12.
Nagarajan H, Gunasekaran T. Xerostomia diagnosis and management. Int J Community Dent 2021;9:70-3. doi: 10.4103/ijcd.ijcd_9_22.
Brimhall J, Jhaveri MA, Yepes JF. Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study. Spec Care Dentist 2013;33(3):123-7. doi: 10.1111/scd.12010.
Greenwood M, Meechan JG. The respiratory system and dental practice. General Medicine and Surgery for Dental Practitioners: In: Greenwood M, Meechan JG. General Medicine and Surgery for Dental Practitioners. BDJ Clinician’s Guides. Cham: Springer; 2019. p. 27-37. doi: 10.1007/978-3-319-97737-9_3.
Lewis MAO, Williams DW. Diagnosis and management of oral candidosis. Br Dent J 2017;223(9):675-81. doi: 10.1038/sj.bdj.2017.886.
Madeswaran S, Jayachandran S. Sodium bicarbonate: A review and its uses in dentistry. Indian J Dent Res 2018;29(5):672-7. doi: 10.4103/ijdr.IJDR_30_17.
Taylor M, Brizuela M, Raja A. Oral Candidiasis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
Lang NP, Schätzle MA, Löe H. Gingivitis as a risk factor in periodontal disease. J Clin Periodontol 2009;36 Suppl 10:3-8. doi: 10.1111/j.1600-051X.2009.01415.x.
DOI: https://doi.org/10.21164/pomjlifesci.941
Copyright (c) 2023 Marcin Pasternak
License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/